Article ID Journal Published Year Pages File Type
8219835 International Journal of Radiation Oncology*Biology*Physics 2014 10 Pages PDF
Abstract
Our study results indicate that dose-escalated EBRT has been widely adopted by radiation oncologists treating prostate cancer in the United States. The proportion of patients receiving dose-escalated EBRT increased nearly 20% between 2006 and 2011. We observed high utilization rates of dose-escalated EBRT within all disease risk groups. Adoption of intensity modulated radiation therapy was strongly associated with use of dose-escalated treatment.
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Authors
, , , , , ,